ABACAVIR/LAMIVUDINE LAPL 600/300 abacavir (as hydrochloride) 600 mg and lamivudine 300 mg film-coated tablet blister pack

Страна: Австралия

Язык: английский

Источник: Department of Health (Therapeutic Goods Administration)

Активный ингредиент:

lamivudine, Quantity: 300 mg; abacavir hydrochloride monohydrate, Quantity: 714.162 mg (Equivalent: abacavir, Qty 600 mg)

Доступна с:

Lupin Australia Pty Limited

ИНН (Международная Имя):

abacavir hydrochloride monohydrate,Lamivudine

Фармацевтическая форма:

Tablet, film coated

состав:

Excipient Ingredients: microcrystalline cellulose; crospovidone; povidone; magnesium stearate; ferric oxide; titanium dioxide; hypromellose; sunset yellow FCF; polysorbate 80; macrogol 400

Администрация маршрут:

Oral

Штук в упаковке:

30 tablets (opaque white PVC/PVDC Al blister pack)

Тип рецепта:

(S4) Prescription Only Medicine

Терапевтические показания :

ABACAVIR/LAMIVUDINE LAPL is a combination of two nucleoside analogues (abacavir and lamivudine). ABACAVIR/LAMIVUDINE LAPL is indicated in antiretroviral combination therapy for the treatment of Human Immunodeficiency Virus (HIV) infection in adults and adolescents from 12 years of age.

Обзор продуктов:

Visual Identification: Orange coloured, modified capsule shaped, biconvex, film-coated tablets debossed with 300 on one side and 600 on the other side.; Container Type: Blister Pack; Container Material: PVC/PVDC; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius

Статус Авторизация:

Licence status A

Дата Авторизация:

2017-10-06